Only 12% of Americans are metabolically healthy. These 8 biomarkers reveal where you stand.
Metabolic health is defined by the optimal functioning of the body's energy management systems — the integrated processes of glucose regulation, lipid metabolism, blood pressure control, and inflammatory balance that together determine risk for type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, dementia, and many cancers. A 2019 study by Dr. Meghan Riekert and colleagues published in Metabolic Syndrome and Related Disorders established that only 12.2 percent of American adults meet all five standard criteria for metabolic health: optimal waist circumference, blood pressure, fasting glucose, triglycerides, and HDL cholesterol without medication.
This stunning statistic — 88 percent of Americans are metabolically suboptimal by at least one measure — reflects a health crisis that is largely invisible because metabolic dysfunction progresses silently for years or decades before producing symptomatic disease. The most powerful tool for identifying and tracking metabolic health status is biomarker testing — specific blood, clinical, and imaging measurements that reveal the current state of your metabolic machinery with precision unavailable through symptoms alone.
## Biomarker 1–2: Blood Sugar Markers
"Only 12% of American adults qualify as metabolically healthy by all five standard criteria. If you haven't measured your metabolic biomarkers, you're almost certainly navigating without a map."
Carb Cycling for Weight Loss
Strategic carb manipulation for fat loss while maintaining muscle mass.
Fasting glucose and HbA1c are the standard blood sugar markers included in most routine bloodwork, but they miss the most sensitive early indicator of metabolic dysfunction. Fasting glucose becomes abnormal (above 100 mg/dL) only after years of progressive insulin resistance, when the pancreas can no longer compensate for cellular insulin resistance through increased insulin secretion. HbA1c reflects average glucose over approximately three months and is similarly insensitive to early-stage insulin resistance.
We Don't Just Tell You What to Do.
We Tell You Why You Failed Before.
Most people treat health like a math problem — but it's a behavioural problem. Our combined psychology assessment identifies the patterns sabotaging both your diet and fitness progress, then builds one unified plan that works with your real personality.
More likely to succeed. Programs incorporating CBT result in significantly better long-term weight maintenance.
Diet + Fitness combined · Completely free · ~4 minutes
8 diet profiles + 8 fitness profiles — which combination are you?
Fasting insulin is the most sensitive early marker of metabolic dysfunction, rising years before fasting glucose or HbA1c becomes abnormal. When cells become insulin-resistant, the pancreas compensates by secreting more insulin to achieve the same glucose-lowering effect — fasting insulin rises as a compensatory response that maintains normal glucose levels at the cost of chronically elevated insulin. Optimal fasting insulin is below 7 μIU/mL; levels above 10 μIU/mL suggest significant insulin resistance. HOMA-IR (homeostatic model assessment of insulin resistance) — calculated as fasting glucose (mg/dL) × fasting insulin (μIU/mL) ÷ 405 — quantifies insulin resistance; a HOMA-IR above 2.0 indicates insulin resistance, with values above 2.9 indicating moderate to severe dysfunction. Requesting fasting insulin alongside standard glucose testing is the single most valuable addition to a metabolic health panel.
"Fasting insulin is the most sensitive early marker of metabolic dysfunction — it rises years before fasting glucose or HbA1c becomes abnormal. Yet it's almost never included in standard bloodwork."
## Biomarker 3–4: Lipid Panel Deep Dive
Standard total cholesterol is nearly useless as a metabolic health marker — both because the total includes protective HDL and because particle size and number are more predictive of risk than concentration. The most informative standard lipid markers for metabolic health are triglycerides and HDL cholesterol, and their ratio is particularly powerful. The triglyceride-to-HDL ratio is among the most accurate non-laboratory predictors of insulin resistance: a ratio below 1.5 (in mg/dL units) indicates good insulin sensitivity and low cardiovascular risk; a ratio above 3.0 strongly suggests insulin resistance and elevated small, dense LDL particle burden.
For more detailed lipid assessment, apolipoprotein B (ApoB) is the most accurate predictor of atherosclerotic cardiovascular disease risk available through standard bloodwork. Each LDL particle contains exactly one ApoB molecule, so ApoB directly measures LDL particle number rather than the size-confounded concentration measured by standard LDL cholesterol. Research consistently shows that ApoB is a stronger predictor of cardiovascular events than LDL cholesterol, particularly in metabolically unhealthy individuals where small, dense LDL particles (each carrying less cholesterol but full cardiovascular risk) may produce dangerously high ApoB at seemingly normal LDL cholesterol levels. Optimal ApoB is below 80 mg/dL.
"The triglyceride-to-HDL ratio predicts insulin resistance and cardiovascular risk with remarkable accuracy. A ratio below 1.5 indicates metabolic health; above 3.0 indicates significant insulin resistance."
## Biomarker 5–6: Blood Pressure and Waist Circumference
Blood pressure above 120/80 mmHg — the threshold for 'elevated' blood pressure by current AHA guidelines — is among the most sensitive early signs of vascular and metabolic dysfunction. Optimal blood pressure for metabolic health is below 120/80 mmHg consistently across multiple measurements; values above 130/80 mmHg indicate hypertension Stage 1 requiring active intervention. Home blood pressure monitoring (average of three readings, taken after five minutes of rest) provides more accurate metabolic health data than office measurements affected by white coat hypertension.
Waist circumference — measured at the level of the iliac crest (top of the hip bones), not the belt line — is the simplest and most clinically validated proxy for visceral fat burden. Optimal waist circumference thresholds for metabolic health are below 35 inches (88 cm) for women and below 40 inches (102 cm) for men of European descent, with lower thresholds recommended for South and East Asian populations. Waist circumference is a stronger predictor of metabolic disease and all-cause mortality than BMI in multiple large prospective studies.
"High-sensitivity CRP reveals the chronic low-grade inflammation that silently drives cardiovascular disease, metabolic dysfunction, and accelerated aging — often years before symptoms appear."
Predict How Food Affects Your Body
Before You Eat.
Log glucose readings, energy levels, and sleep quality to build your personal metabolic fingerprint. Our platform then predicts the glucose spike, energy impact, and metabolic score of any meal before you eat it — and suggests real-time tweaks like 'add avocado to blunt the glucose spike' right on the meal card.
Smarter than calorie counting. Two meals with identical calories can have wildly different effects on your energy, cravings, and fat storage. Metabolic Intelligence reveals the difference.
Free to use · No credit card required
## Biomarker 7–8: Inflammatory and Hormonal Markers
High-sensitivity C-reactive protein (hs-CRP) measures systemic low-grade inflammation — the smoldering, chronic inflammatory state that underlies atherosclerosis, insulin resistance, and metabolic disease progression. Optimal hs-CRP is below 1.0 mg/L; values of 1.0 to 3.0 mg/L indicate intermediate inflammatory risk; above 3.0 mg/L indicates high inflammatory burden. hs-CRP above 3.0 mg/L doubles cardiovascular event risk independent of traditional risk factors. Dietary changes — particularly adoption of a Mediterranean-style diet, reduction of ultra-processed foods, and increased omega-3 intake — produce measurable hs-CRP reductions within 4 to 12 weeks.
Uric acid — a byproduct of fructose and purine metabolism — is an emerging metabolic health biomarker with strong associations with gout, hypertension, insulin resistance, and cardiovascular disease. Optimal uric acid is below 5.5 mg/dL for both sexes; values above 6.0 mg/dL in women and 7.0 mg/dL in men indicate hyperuricemia. Elevated uric acid is both a marker of fructose overconsumption and a direct inhibitor of endothelial nitric oxide synthase — reducing nitric oxide availability and contributing to hypertension and endothelial dysfunction. Tracking these eight biomarkers quarterly — or at minimum annually — provides a comprehensive metabolic health score that guides precision lifestyle interventions with measurable targets far more informative than scale weight alone.
Dr. Sarah Mitchell
Endocrinologist
Expert contributor at our health & wellness platform, bringing evidence-based insights to help you achieve your nutrition and fitness goals.
